Cost-effectiveness analysis of a bone metastasis cancer board for skeletal-related events of breast cancer
The treatment strategy developed by involving a BM cancer board is more cost-effective than that developed without involving such a board, justifying healthcare resource allocation for implementation of this board.
Authors
- Shin Hitachi (ORCID: https://orcid.org/0009-0005-5529-053X)
- Hirotaka Kurata
- T Aizawa
- Jun Iwatsu (ORCID: https://orcid.org/0000-0003-2561-8379)
- Sota Oguro (ORCID: https://orcid.org/0000-0002-7101-7382)
- Munenori Watanuki (ORCID: https://orcid.org/0000-0003-3963-7749)
- Satoru Yanagaki (ORCID: https://orcid.org/0000-0002-3646-4558)
- Takayuki Yamada (ORCID: https://orcid.org/0000-0002-2441-0149)
- Kei Takase (ORCID: https://orcid.org/0000-0003-0931-9942)
- Hiroshi Tada (ORCID: https://orcid.org/0000-0003-2670-8982)
- Shinichirou Yoshida (ORCID: https://orcid.org/0000-0003-1110-2363)
- Yojiro Ishikawa
Institutions
- Tohoku University (JP)
- Ijinkai Takeda General Hospital (JP)
- Tohoku Medical and Pharmaceutical University Hospital (JP)
- Sendai City Hospital (JP)
- Sendai Shakai Hoken Hospital (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1093/jjco/hyag034
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00